Clinical Trial: Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial): SAFETY AND IMMUNOGENICITY OF PANDEMIC INFLUENZA VACCINE IN KIDNEY TRANSPLANT RECIPIENTS

U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240558) titled 'Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial): SAFETY AND IMMUNOGENICITY OF PANDEMIC INFLUENZA VACCINE IN KIDNEY TRANSPLANT RECIPIENTS' on Nov. 16.

Brief Summary: Influenza is an important pathogen in transplant recipients. The current widespread outbreak of highly pathogenic H5N1 avian influenza (HPAI) in livestock, and the occurrence of several human cases of infection suggest that the next influenza pandemic may be soon approaching. Transplant patients will likely be uniquely predisposed to serious infection with high morbidity and mortality. There are a number of important reasons that evaluation of preventio...